• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Celgene Corporation (CELG)

    -NasdaqGS
    112.82 Up 2.73(2.48%) 4:00PM EST
    |After Hours : 112.53 Down 0.29 (0.26%) 5:01PM EST
    Add to Portfolio
    Prev Close:110.09
    Open:110.21
    Bid:112.53 x 100
    Ask:113.19 x 100
    1y Target Est:116.68
    Beta:2
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:109.16 - 113.11
    52wk Range:66.85 - 119.84
    Volume:4,869,401
    Avg Vol (3m):5,084,740
    Market Cap:90.11B
    P/E (ttm):59.10
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CELG

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 2.48%90.11B
    JNJUp 1.27%291.30B

    Key Statistics

    Forward P/E (1 yr):23.21
    P/S (ttm):11.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.68
    Quarterly EPS Est (Dec-14) :1.00
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback